Cargando…

Ganirelix and the prevention of premature luteinizing hormone surges

Ganirelix is a gonadotropin-releasing hormone (GnRH) antagonist with high antagonistic activity that blocks the GnRH receptor by competitive binding. A daily dose of 0.25 mg of ganirelix was sel5ected after a phase II study because it was the minimal, effective daily dose to prevent premature lutein...

Descripción completa

Detalles Bibliográficos
Autor principal:	Mannaerts, Bernadette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Special Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201301/ https://www.ncbi.nlm.nih.gov/pubmed/37223764 http://dx.doi.org/10.1016/j.xfre.2023.02.009

Ejemplares similares

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
por: Lambalk, Cornelis B.
Publicado: (2023)

Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation
por: Frattarelli, John L, et al.
Publicado: (2013)

The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation
por: Doğan Durdağ, Gülşen, et al.
Publicado: (2021)

Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
por: Zhu, Xiuxian, et al.
Publicado: (2015)

Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization
por: Kochhar, Puneet Kaur, et al.
Publicado: (2020)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
por: Chen, Qiuju, et al.
Publicado: (2019)

Hypothalamic Astrocyte Development and Physiology for Neuroprogesterone Induction of the Luteinizing Hormone Surge
por: Sinchak, Kevin, et al.
Publicado: (2020)

Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles
por: Tandulwadkar, Sunita, et al.
Publicado: (2023)

Effects of clomiphene citrate for prevention of premature luteinizing hormone surge in those undergoing intrauterine insemination outcome: A randomized, double-blind, placebo-controlled trial
por: Zarei, Afsoon, et al.
Publicado: (2018)

The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles
por: Choi, Min Hye, et al.
Publicado: (2013)

Artificial Intelligence in Retinopathy of Prematurity Diagnosis
por: Scruggs, Brittni A., et al.
Publicado: (2020)

Effect of oral Utrogestan in comparison with Cetrotide on preventing luteinizing hormone surge in IVF cycles: A randomized controlled trial
por: Ghasemzadeh, Alieh, et al.
Publicado: (2020)

An administration of TAK-683 at a minimally effective dose for luteinizing hormone stimulation under the absence of the ovary induces luteinizing hormone surge in ovary-intact goats
por: KANAI, Nahoko, et al.
Publicado: (2017)

The Contribution of the Circadian Gene Bmal1 to Female Fertility and the Generation of the Preovulatory Luteinizing Hormone Surge
por: Tonsfeldt, Karen J, et al.
Publicado: (2019)

Effects of metformin and ganirelix on subcutaneous endometriosis in a mouse model of autophagy-related cell death
por: Sönmez Ünal, Gamze, et al.
Publicado: (2023)

Convolutional Neural Network Based on Fluorescein Angiography Images for Retinopathy of Prematurity Management
por: Lepore, Domenico, et al.
Publicado: (2020)

Intracerebroventricular Infusion of Vasoactive Intestinal Peptide Rescues the Luteinizing Hormone Surge in Middle-Aged Female Rats
por: Sun, Yan, et al.
Publicado: (2012)

Ultradian rhythms in heart rate variability and distal body temperature anticipate onset of the luteinizing hormone surge
por: Grant, Azure D., et al.
Publicado: (2020)

The Free Hormone Hypothesis: When, Why, and How to Measure the Free Hormone Levels to Assess Vitamin D, Thyroid, Sex Hormone, and Cortisol Status
por: Bikle, Daniel D
Publicado: (2020)

Inhibiting Production of New Brain Cells during Puberty or Adulthood Blunts the Hormonally Induced Surge of Luteinizing Hormone in Female Rats
por: Mohr, Margaret A., et al.
Publicado: (2017)

Gonadotropin-releasing hormone: incredible 50 years
por: Paulson, Richard J., et al.
Publicado: (2023)

Early preclinical work with gonadotropin-releasing hormone analogues
por: Gordon, Keith
Publicado: (2023)

Plus Disease in Retinopathy of Prematurity: Convolutional Neural Network Performance Using a Combined Neural Network and Feature Extraction Approach
por: Yildiz, Veysi M., et al.
Publicado: (2020)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
por: Chwalisz, Kristof
Publicado: (2023)

Exploring the hormonal and neural correlates of paternal protective behavior to their infants
por: Lotz, Anna M., et al.
Publicado: (2020)

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
por: Fleming, Richard
Publicado: (2022)

Effect of Age, Duration of Exposure, and Dose of Atrazine on Sexual Maturation and the Luteinizing Hormone Surge in the Female Sprague–Dawley Rat
por: Breckenridge, Charles B., et al.
Publicado: (2015)

Optogenetic Activation of Arcuate Kisspeptin Neurons Generates a Luteinizing Hormone Surge-Like Secretion in an Estradiol-Dependent Manner
por: Lin, Xian-Hua, et al.
Publicado: (2021)

Pulsatile gonadotropin-releasing hormone: clinical applications of a physiologic paradigm
por: Filicori, Marco
Publicado: (2023)

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine
por: Saleh, Farrah L., et al.
Publicado: (2023)

A Prospective Randomised Comparative Clinical Trial Study of Luteal Phase Letrozole versus Ganirelix Acetate Administration to Prevent Severity of Early Onset OHSS in ARTs
por: Choudhary, Rana Afzal, et al.
Publicado: (2021)

Veteran peer suicide prevention: A community‐based peer prevention model
por: Beehler, Sarah, et al.
Publicado: (2021)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka
por: Ogiwara, Katsueki, et al.
Publicado: (2013)

Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists
por: Spicer, Darcy V, et al.
Publicado: (2000)

IMI Prevention of Myopia and Its Progression
por: Jonas, Jost B., et al.
Publicado: (2021)

Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: strategic insights from key stakeholders(†)
por: Hemmerling, Anke, et al.
Publicado: (2020)

Optogenetic stimulation of Kiss1(ARC) terminals in the AVPV induces surge-like luteinizing hormone secretion via glutamate release in mice
por: Shen, Xi, et al.
Publicado: (2022)

Differential Effects of Continuous Exposure to the Investigational Metastin/Kisspeptin Analog TAK-683 on Pulsatile and Surge Mode Secretion of Luteinizing Hormone in Ovariectomized Goats
por: TANAKA, Tomomi, et al.
Publicado: (2013)

A premature luteinizing hormone surge without elevated progesterone levels has no adverse effect on cumulative live birth rate in patient undergoing a flexible GnRH antagonist protocol: a retrospective study
por: Zhang, Yangyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lcpf9g5nqbe5aj4jotgkddqj11